Cargando…

Effects of sodium-glucose co-transporter 2 (SGLT2) inhibitors on renal outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: A protocol for systematic review and meta-analysis

BACKGROUND: Many studies have shown the effects of SGLT2 inhibitors on type 2 diabetes, but the effects in patients with type 2 diabetes with chronic kidney disease remains unclear. This study aims to evaluate the effects of SGLT2 inhibitors on renal outcomes in patients with type 2 diabetes mellitu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Baisong, Dong, ChunXia, Hu, ZhiJuan, Liu, Bing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	5200
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909223/ https://www.ncbi.nlm.nih.gov/pubmed/33663074 http://dx.doi.org/10.1097/MD.0000000000024655

Ejemplares similares

Sodium Glucose Co-transporter Type 2 (SGLT2) Inhibitors: Targeting the Kidney to Improve Glycemic Control in Diabetes Mellitus
por: Bays, Harold
Publicado: (2013)

A meta-analysis of renal outcomes in living kidney donors
por: Li, Sha-Sha, et al.
Publicado: (2016)

ADMA predicts major adverse renal events in patients with mild renal impairment and/or diabetes mellitus undergoing coronary angiography
por: Heunisch, Fabian, et al.
Publicado: (2017)

The influence of blood pressure patterns on renal outcomes in patients with chronic kidney disease: The long-term follow up result of the APrODiTe-2 study
por: Cha, Ran-hui, et al.
Publicado: (2020)

Sodium glucose transporter 2 (SGLT2) inhibition and ketogenesis
por: Kalra, Sanjay, et al.
Publicado: (2015)

Clinical And Biochemical Outcomes Of Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors In Type 2 Diabetes Mellitus Patients
por: Saleem, Muhammad, et al.
Publicado: (2021)

The diagnostic accuracy of urinary [TIMP-2]·[IGFBP7] for acute kidney injury in adults: A PRISMA-compliant meta-analysis
por: Liu, Chao, et al.
Publicado: (2017)

Dapagliflozin-associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes mellitus: A case report
por: Lee, In Hee, et al.
Publicado: (2020)

Risk factors of gender for renal progression in patients with early chronic kidney disease
por: Chang, Po-Ya, et al.
Publicado: (2016)

Role of MCP-1/CCR2 axis in renal fibrosis: Mechanisms and therapeutic targeting
por: He, Shiyang, et al.
Publicado: (2023)

Alteration and association between serum ACE2/ angiotensin(1-7)/Mas axis and oxidative stress in chronic kidney disease: A pilot study
por: Shi, Chengqian, et al.
Publicado: (2020)

The Power of Renal Function Estimation Equations for Predicting Long-Term Kidney Graft Survival: A Retrospective Comparison of the Chronic Kidney Disease Epidemiology Collaboration and the Modification of Diet in Renal Disease Study Equations
por: Choi, Hoon Young, et al.
Publicado: (2016)

β2-microglobulin is an independent indicator of acute kidney injury and outcomes in patients with intracerebral hemorrhage
por: Wang, Rui, et al.
Publicado: (2020)

Excretion of glucose analogue with SGLT2 affinity predicts response effectiveness to sodium glucose transporter 2 inhibitors in patients with type 2 diabetes mellitus
por: Geist, Barbara Katharina, et al.
Publicado: (2023)

Renal and pulmonary thrombotic microangiopathy triggered by proteasome-inhibitor therapy in patient with smoldering myeloma: A renal biopsy and autopsy case report
por: Cassol, Clarissa A., et al.
Publicado: (2019)

Renal volume and cardiovascular risk assessment in normotensive autosomal dominant polycystic kidney disease patients
por: Sans, Laia, et al.
Publicado: (2016)

Comprehensive analysis of mutations of renal cell carcinoma in an autosomal dominant polycystic kidney disease patient
por: Shim, Kwang Eon, et al.
Publicado: (2020)

Fournier's Gangrene and Sodium-glucose Co-transporter 2(SGLT2) Inhibitors: Our Experience
por: Dass, Ashwitha S., et al.
Publicado: (2019)

HLA-DR, and not PLA2R, is expressed on the podocytes in kidney allografts in de novo membranous nephropathy
por: Wen, Jiqiu, et al.
Publicado: (2016)

Electrolyte and mineral disturbances in septic acute kidney injury patients undergoing continuous renal replacement therapy
por: Jung, Su-Young, et al.
Publicado: (2016)

Serum VEGF-D level is correlated with renal dysfunction and proteinuria in patients with diabetic chronic kidney disease
por: Nguyen, Thi Thuy Uyen, et al.
Publicado: (2022)

Predictors of chronic kidney disease in type 2 diabetes: A longitudinal study from the AMD Annals initiative
por: De Cosmo, Salvatore, et al.
Publicado: (2016)

Recurrent flash pulmonary edema in unilateral renal artery stenosis with contralateral kidney shrinkage: A case report
por: Cheon, Ji Eun, et al.
Publicado: (2023)

Urinary metalloproteinases and tissue inhibitors of metalloproteinases as potential early biomarkers for renal fibrosis in children with nephrotic syndrome
por: Bieniaś, Beata, et al.
Publicado: (2018)

Use of Sodium-Glucose Transport Protein 2 (SGLT2) Inhibitor Remogliflozin and Possibility of Acute Kidney Injury in Type-2 Diabetes
por: Jain, Rajesh, et al.
Publicado: (2022)

Case report: Brincidofovir-induced reversible severe acute kidney injury in 2 solid-organ transplant for treatment of cytomegalovirus infection
por: Faure, Emmanuel, et al.
Publicado: (2016)

Beneficial effect of statin on preventing contrast-induced acute kidney injury in patients with renal insufficiency: A meta-analysis
por: Cho, AJin, et al.
Publicado: (2020)

Efficacy and safety of dapagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in diabetes mellitus
por: Fioretto, Paola, et al.
Publicado: (2015)

Review on sodium-glucose cotransporter 2 inhibitor (SGLT2i) in diabetes mellitus and heart failure
por: Pradhan, Akshyaya, et al.
Publicado: (2019)

Coenzyme Q10 supplementation therapy for 2 children with proteinuria renal disease and ADCK4 mutation: Case reports and literature review
por: Feng, Chunyue, et al.
Publicado: (2017)

Correlation between nerve conduction changes and BETA-2 microglobulin concentration in chronic kidney disease patients on hemodialysis combined with hemodiafiltration online
por: Nguyen, Nghia Nhu, et al.
Publicado: (2023)

Prevalence of depression and suicidal ideation increases proportionally with renal function decline, beginning from early stages of chronic kidney disease
por: Jhee, Jong H., et al.
Publicado: (2017)

Sodium-glucose co-transporter 2 (SGLT2) inhibitors: a growing class of antidiabetic agents
por: Vivian, Eva M
Publicado: (2014)

Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors: A Review of Their Basic and Clinical Pharmacology
por: Kalra, Sanjay
Publicado: (2014)

Exploring Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors for Organ Protection in COVID-19
por: Fernandez-Fernandez, Beatriz, et al.
Publicado: (2020)

Out-of-Pocket Costs for SGLT-2 (Sodium-Glucose Transport Protein-2) Inhibitors in the United States
por: Aggarwal, Rahul, et al.
Publicado: (2021)

Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary
por: Mascolo, Annamaria, et al.
Publicado: (2022)

Lactate clearance is associated with mortality in septic patients with acute kidney injury requiring continuous renal replacement therapy: A cohort study
por: Passos, Rogério da Hora, et al.
Publicado: (2016)

Time on previous renal replacement therapy is associated with worse outcomes of COVID-19 in a regional cohort of kidney transplant and dialysis patients
por: Villa, Luigi, et al.
Publicado: (2021)

Glomerulonephritis and granulomatous vasculitis in kidney as a complication of the use of BRAF and MEK inhibitors in the treatment of metastatic melanoma: A case report
por: Maanaoui, Mehdi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_u5rtc6v870hifdlbrul50q50t2